Loading clinical trials...
Loading clinical trials...
Association Between Hypertension, Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19
Conditions
Start Date
May 1, 2020
Primary Completion Date
June 1, 2020
Completion Date
July 1, 2020
Last Updated
May 5, 2020
NCT06082518
NCT07221162
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
Versailles Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions